PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23454147-4	2013	CG ameliorated DNCB-induced dermatitis severity, serum levels of IgE and TARC, and mRNA expression of TARC, TNF-alpha, IFN-gamma, IL-4, IL-5, and IL-13 in mice.	Dinitrochlorobenzene	15-19	interleukin 13	Mus musculus	146-151	
11906244-6	2002	The Th2 cytokines IL4, IL10, and IL13 were significantly increased in response to TMA compared to DNCB, with optimal detection occurring 14 days following initial exposure.	Dinitrochlorobenzene	98-102	interleukin 13	Mus musculus	33-37	
23760007-8	2013	Rutin suppressed DFE/DNCB-induced expression of interleukin (IL)-4, IL-5, IL-13, IL-31, IL-32 and interferon (INF)-gamma in the tissue.	Dinitrochlorobenzene	21-25	interleukin 13	Mus musculus	74-79	
21511060-8	2011	In addition, DA-9601 suppressed DFE/DNCB-induced expression of IL-4, IL-13, IL-31, and TNF-alpha in the ears.	Dinitrochlorobenzene	36-40	interleukin 13	Mus musculus	69-74	
15297022-15	2004	Another control, dinitrochlorobenzene (DNCB), a contact sensitizer, also responded as expected, producing smaller but statistically significant increases in IgE and in mRNA for IL-4 and IL-13 but not in the levels of these cytokines.	Dinitrochlorobenzene	17-37	interleukin 13	Mus musculus	186-191	
15297022-15	2004	Another control, dinitrochlorobenzene (DNCB), a contact sensitizer, also responded as expected, producing smaller but statistically significant increases in IgE and in mRNA for IL-4 and IL-13 but not in the levels of these cytokines.	Dinitrochlorobenzene	39-43	interleukin 13	Mus musculus	186-191	
12424743-5	2002	In contrast, TMA and DNCB induced similar levels of IL-4 and IL-13 mRNA in the BALB/C mice.	Dinitrochlorobenzene	21-25	interleukin 13	Mus musculus	61-66	
35634683-6	2022	Moreover, SHE significantly inhibited the proliferation of mast cells and decreased the expression of IL-13 on CD4+ cells prompted by elevated thymic stromal lymphopoietin (TSLP) expression in DNCB-induced AD in mice.	Dinitrochlorobenzene	193-197	interleukin 13	Mus musculus	102-107	
32487782-6	2020	DNCB-induced increase of lymph nodes sizes and elevated inflammatory cytokines (IL-4, IL-13, IL-17, and IFN-gamma) in lymph nodes were also significantly reduced by the JTE-013 treatment.	Dinitrochlorobenzene	0-4	interleukin 13	Mus musculus	86-91	
30877873-7	2019	Both DHMEQ and tacrolimus suppress DNCB-induced increase of serum total IgE and attenuate expression of inflammatory factors IL-4, IL-6, IL-13, IL-1beta and interferon (IFN)-gamma in the disrupted ear tissues.	Dinitrochlorobenzene	35-39	interleukin 13	Mus musculus	137-142	
32279475-8	2020	Treatment with 4-CMTB reduced DNCB-induced increases in Th2 cytokine (IL-4 and IL-13) levels in the ears, but did not alter Th1 or Th17 cytokine (IFN-gamma and IL-17) levels.	Dinitrochlorobenzene	30-34	interleukin 13	Mus musculus	79-84	
28159725-12	2017	SC+TOL also decreased serum IgE and IgG1 levels and the expression of IFN-gamma, IL-4, and IL-13 mRNA in dorsal skin in DNCB-treated Nc/Nga mice.	Dinitrochlorobenzene	120-124	interleukin 13	Mus musculus	91-96	
29910732-8	2018	Administration of BLM and DNCB increased the levels of IL-4 and IL-13 production in spleen cells and eotaxin-2 mRNA expression in dorsal skin, compared to NC/Nga mice treated with DNCB alone.	Dinitrochlorobenzene	26-30	interleukin 13	Mus musculus	64-69	
26840656-8	2016	Furthermore, SCR suppressed DFE/DNCB-induced expression of IL-4, IL-13, IL-17, IL-18, TSLP, and IFN-gamma genes in the ear tissue.	Dinitrochlorobenzene	32-36	interleukin 13	Mus musculus	65-70	
25170825-9	2014	In addition to reducing the DNCB-induced increase in serum IgE, 7,8,4"-THIF also lowered skin lesion levels of the chemokine thymus and activation regulated chemokine; Th2 cytokines interleukin (IL)-4, IL-5, and IL-13; and Th1 cytokines IL-12 and interferon-gamma.	Dinitrochlorobenzene	28-32	interleukin 13	Mus musculus	212-217